NCT01116440 A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis Status TERMINATED Phase PHASE2
NCT01113047 Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine Status COMPLETED Phase PHASE3
NCT01111526 Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD) Status COMPLETED Phase PHASE1/PHASE2
NCT01108445 Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT01104571 Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer Status UNKNOWN Phase PHASE3
NCT01103024 Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis Status WITHDRAWN Phase PHASE3
NCT01099436 Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT01095822 Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics Status UNKNOWN Phase PHASE4
NCT01092065 Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia Status COMPLETED Phase PHASE2
NCT01089855 Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain Status COMPLETED Phase PHASE4
NCT01089595 Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST) Status TERMINATED Phase PHASE2
NCT01087008 Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse Status COMPLETED Phase PHASE4
NCT01083589 Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT01080963 Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections Status COMPLETED Phase PHASE4
NCT01070316 Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) Status COMPLETED Phase PHASE1/PHASE2
NCT01070043 To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone Status COMPLETED Phase PHASE4
NCT01070030 Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension Status COMPLETED Phase PHASE4
NCT01069692 Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients Status COMPLETED Phase PHASE3